Search Results - "OSEROFF, A. R"

Refine Results
  1. 1

    Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rate by HENDERSON, B. W, BUSCH, T. M, GRECO, W. R, OSEROFF, A. R, VAUGHAN, L. A, FRAWLEY, N. P, BABICH, D, SOSA, T. A, ZOLLO, J. D, DEE, A. S, COOPER, M. T, BELLNIER, D. A

    Published in Cancer research (Chicago, Ill.) (01-02-2000)
    “…At high fluence rates in animal models, photodynamic therapy (PDT) can photochemically deplete ambient tumor oxygen through the generation of singlet oxygen,…”
    Get full text
    Journal Article
  2. 2

    Comparison of Photodynamic Targets in a Carcinoma Cell Line and Its Mitochondrial DNA-Deficient Derivative by Morgan, J., Potter, W. R., Oseroff, A. R.

    Published in Photochemistry and photobiology (01-06-2000)
    “…The relative contribution, to cell death, of photodynamic damage to respiratory proteins (known targets of photodynamic therapy with many photosensitizers) and…”
    Get full text
    Journal Article
  3. 3

    Synthesis of β-Galactose-Conjugated Chlorins Derived by Enyne Metathesis as Galectin-Specific Photosensitizers for Photodynamic Therapy by Zheng, Gang, Graham, Andrew, Shibata, Masayuki, Missert, Joseph R, Oseroff, Allan R, Dougherty, Thomas J, Pandey, Ravindra K

    Published in Journal of organic chemistry (28-12-2001)
    “…A first report on the synthesis and biological evaluation of the β-galactose-conjugated purpurinimides (a class of chlorins containing a six-membered fused…”
    Get full text
    Journal Article
  4. 4

    Photodynamic therapy for the treatment of extramammary Paget's disease by Shieh, S., Dee, A.S., Cheney, R.T., Frawley, N.P., Zeitouni, N.C., Oseroff, A.R.

    Published in British journal of dermatology (1951) (01-06-2002)
    “…Summary Background Surgical and ablative treatment modalities for extramammary Paget's disease (EMPD) have high recurrence rates and can be associated with…”
    Get full text
    Journal Article
  5. 5

    Expression of the peripheral benzodiazepine receptor is decreased in skin cancers in comparison with normal skin by Morgan, J., Oseroff, A.R., Cheney, R.T.

    Published in British journal of dermatology (1951) (01-10-2004)
    “…Summary Background  The peripheral benzodiazepine receptor (PBR) is an 18‐kDa protein receptor mainly found on the outer mitochondrial membrane of cells. The…”
    Get full text
    Journal Article
  6. 6

    Prognostic factors and evaluation of mycosis fungoides and Sézary syndrome by Toro, Jorge R., Stoll, Howard L., Stomper, Paul C., Oseroff, Allan R.

    “…Background: Staging evaluations of patients with mycosis fungoides (MF) and Sézary syndrome (SS) are performed to individualize therapy and to predict…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Ceramic-Based Nanoparticles Entrapping Water-Insoluble Photosensitizing Anticancer Drugs:  A Novel Drug−Carrier System for Photodynamic Therapy by Roy, Indrajit, Ohulchanskyy, Tymish Y, Pudavar, Haridas E, Bergey, Earl J, Oseroff, Allan R, Morgan, Janet, Dougherty, Thomas J, Prasad, Paras N

    Published in Journal of the American Chemical Society (02-07-2003)
    “…A novel nanoparticle-based drug carrier for photodynamic therapy is reported which can provide stable aqueous dispersion of hydrophobic photosensitizers, yet…”
    Get full text
    Journal Article
  9. 9

    Mitochondria-based photodynamic anti-cancer therapy by Morgan, Janet, Oseroff, Allan R

    Published in Advanced drug delivery reviews (02-07-2001)
    “…As photodynamic therapy (PDT) becomes established as a treatment for cancer, there is increasing interest in identifying critical mechanisms of cell killing…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Intramitochondrial Dyes Allow Selective in vitro Photolysis of Carcinoma Cells by Oseroff, A. R., Ohuoha, D., Ara, G., McAuliffe, D., Foley, J., Cincotta, L.

    “…Carcinoma cell mitochondria preferentially accumulate and retain certain cationic dyes to a much greater extent than most normal cells. Thus, they can…”
    Get full text
    Journal Article
  12. 12

    Synthesis and Evaluation of Chalcogenopyrylium Dyes as Potential Sensitizers for the Photodynamic Therapy of Cancer by Leonard, Kristi A, Nelen, Marina I, Simard, Todd P, Davies, Sherry R, Gollnick, Sandra O, Oseroff, Allan R, Gibson, Scott L, Hilf, Russell, Chen, Lan Bo, Detty, Michael R

    Published in Journal of medicinal chemistry (23-09-1999)
    “…A series of thiopyrylium (2), selenopyrylium (3), and telluropyrylium dyes (4) was prepared via the addition of Grignard reagents to either…”
    Get full text
    Journal Article
  13. 13

    The role of transferrin receptor (CD71) in photodynamic therapy of activated and malignant lymphocytes using the heme precursor delta-aminolevulinic acid (ALA) by Rittenhouse-Diakun, K, Van Leengoed, H, Morgan, J, Hryhorenko, E, Paszkiewicz, G, Whitaker, J E, Oseroff, A R

    Published in Photochemistry and photobiology (01-05-1995)
    “…Endogenously generated protoporphyrin IX (PpIX) from exogenous ALA can be an effective photosensitizer. PpIX accumulation is inversely dependent on available…”
    Get more information
    Journal Article
  14. 14

    Antibody-Targeted Photolysis: Selective Photodestruction of Human T-Cell Leukemia Cells Using Monoclonal Antibody-Chlorin e6 Conjugates by Oseroff, Allan R., Ohuoha, Donald, Hasan, Tayyaba, Bommer, Jerry C., Yarmush, Martin L.

    “…Selective in vitro photodestruction of HPB-ALL human T-cell leukemia cells was accomplished using the photosensitizer chlorin e6 coupled through dextran…”
    Get full text
    Journal Article
  15. 15

    Photofrin photodynamic therapy for treatment of AIDS-related cutaneous Kaposi's sarcoma by BERNSTEIN, Z. P, WILSON, B. D, DOUGHERTY, T. J, OSEROFF, A. R, JONES, C. M, DOZIER, S. E, BROOKS, J. S. J, CHENEY, R, FOULKE, L, MANG, T. S, BELLNIER, D. A

    Published in AIDS (London) (10-09-1999)
    “…Kaposi's sarcoma, the most common malignancy in AIDS patients, often presents with painful cutaneous lesions that are difficult to treat effectively despite a…”
    Get full text
    Journal Article
  16. 16

    A Pulsed Electric Field Enhances Cutaneous Delivery of Methylene Blue in Excised Full-Thickness Porcine Skin by Johnson, Patricia G., Gallo, Stephen A., Hui, Sek Wen, Oseroff, Allan R.

    Published in Journal of investigative dermatology (01-09-1998)
    “…We used electric pulses to permeabilize porcine stratum corneum and demonstrate enhanced epidermal transport of methylene blue, a water-soluble cationic dye…”
    Get full text
    Journal Article
  17. 17

    Immune responses in patients with T-cell lymphoma treated with an anti-idiotype antibody mimicking a highly restricted T-cell antigen by Foon, K A, Oseroff, A R, Vaickus, L, Greenberg, S J, Russell, D, Bernstein, Z, Pincus, S, Köhler, H, Seon, B K, Tahaoglu, E

    Published in Clinical cancer research (01-11-1995)
    “…We generated an IgG1 murine monoclonal anti-idiotype antibody (Ab2) to a highly restricted T-cell antigen designated glycoprotein (gp) 37 that is found on…”
    Get full text
    Journal Article
  18. 18

    Mitochondrial toxicity of cationic photosensitizers for photochemotherapy by MODICA-NAPOLITANO, J. S, JOYAL, J. L, ARA, G, OSEROFF, A. R, APRILLE, J. R

    Published in Cancer research (Chicago, Ill.) (15-12-1990)
    “…The triarylmethane derivative Victoria Blue-BO (VB-BO) and the chalcogenapyrylium (CP) dyes have potential for use in photochemotherapy, because they are taken…”
    Get full text
    Journal Article
  19. 19

    Strategies for selective cancer photochemotherapy: antibody-targeted and selective carcinoma cell photolysis by Oseroff, A R, Ara, G, Ohuoha, D, Aprille, J, Bommer, J C, Yarmush, M L, Foley, J, Cincotta, L

    Published in Photochemistry and photobiology (01-07-1987)
    “…A principle objective in chemotherapy is the development of modalities capable of selectively destroying malignant cells while sparing normal tissues. One new…”
    Get more information
    Journal Article
  20. 20

    Antineoplastic activity, synergism, and antagonism of triarylalkylphosphonium salts and their combinations by Patel, J, Rideout, D, McCarthy, M R, Calogeropoulou, T, Wadwa, K S, Oseroff, A R

    Published in Anticancer research (01-01-1994)
    “…Previously, some of us demonstrated that monocationic phosphonium salt [4-(formylphenyl)methyl]triphenylphosphonium chloride (A) and…”
    Get more information
    Journal Article